ArticleScientific reports2026
Development of an HRM-qRT-PCR platform for fast and cost-effective genotyping of infectious bronchitis virus in Egypt.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Avian infectious bronchitis virus (IBV) is a highly transmissible virus that causes respiratory, reproductive, and renal syndromes, resulting in significant economic losses for the global poultry industry. This study aimed to evaluate the application of high-resolution melting analysis (HRM) as a novel, efficient, and cost-effective tool for the rapid diagnosis and genotyping of Egyptian IBV strains. The investigation focused on the N gene and the 3’ untranslated region (3’ UTR). HRM curves were generated from 435 bp PCR products obtained from 22 IBV-positive avian samples. The purified PCR products, which amplified the 3’ UTR, were sequenced and subsequently compared with analogous S1 gene sequences to differentiate between vaccine strains and field strains, specifically the Egyptian strain 4/91 (GI-13), variant II (GI-23), and the classic strain (GI-1). The high-resolution melting curve analysis (HRM) successfully distinguished vaccine reference strains (Ma5, IB-Primer, 4/91, and Variant II), while the IBV field strains were categorized into three distinct pattern clusters based on the similarity of their melting curves, which were confirmed by S1 gene sequences. Both strains 4/91 and variant II exhibited a deletion of about 15 nucleotides at the terminus of the N-gene compared to classic strains. Closed-tube PCR combined with HRM-curve analysis provides a fast and reliable technique for genotyping IBV strains, including IBV vaccine strains and IBV field strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.